- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 384 results
Client Alert
May 19, 2023
FDA Releases Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
Client Alert
Article · Source: Pratt's Energy Law Report
May 1, 2023
Securities Litigation in the Energy Sector
Client Alert
April 28, 2023
EU and Ukraine to recognize and enforce each other’s court decisions
Client Alert
Client Alert
April 10, 2023
New Medicare Advantage Regulations Add Provider and Beneficiary Protections Against Plan Utilization Management Policies
Client Alert
March 13, 2023
DOJ Corporate Enforcement Policy Revisions Target Executive Compensation, Following Multi-Agency Trend
Client Alert
March 6, 2023
Supreme Court Ruling in AHA v. Becerra May Affect 340B Hospitals' Reimbursement Rights Against Medicare Advantage Plans
Client Alert
March 2, 2023
The Gathering Storm Over Gas Stoves
Client Alert
March 1, 2023
DEA Proposes New Rules for Telemedicine Prescriptions
Client Alert
February 21, 2023
FTC Announces First Enforcement of the Health Breach Notification Rule
Article · Source: Reimbursement Advisor
February 15, 2023
HHS OIG Reports on Telehealth Medicare Program Integrity Risks